Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, April 18, 2024 | Back issues
Courthouse News Service Courthouse News Service

EpiPen Settlement

Mylan will pay $30 million to settle charges of overcharging Medicaid by hundreds of millions of dollars for EpiPen, its largest revenue and profit-generating product, the SEC said Friday.

WASHINGTON — Mylan will pay $30 million to settle SEC charges of overcharging Medicaid by hundreds of millions of dollars for EpiPen, its largest revenue and profit-generating product.

Categories / Health, Securities

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...